Publication | Open Access
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
1K
Citations
23
References
2020
Year
National Institute for Health Research Health Technology Assessment Programme.
| Year | Citations | |
|---|---|---|
Page 1
Page 1